マーケットレポート詳細
生体材料用コラーゲンおよびゼラチンの世界市場：2028年に至る原料別、コラーゲン/ゼラチン別予測
Collagen and Gelatin Market by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopaedic, Cardiovascular, Dental, Surgical, Nerve Repair), End User (Hospitals, Surgical Centers), Region - Global Forecast to 2028
- 出版元：MarketsandMarkets
出版元について - 発行年：2023年7月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文 234ページになります。
- 商品コード：MAM3325
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
生体材料用コラーゲンおよびゼラチンの世界市場規模は2023年で12億ドル、2028年までに16億ドルに達し、予測期間の市場の平均年成長率は6.5%で推移することが見込まれています。
レポートは生体材料用コラーゲンおよびゼラチンの世界市場について2028年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（由来原料別市場、用途別市場、等）を中心に構成されています。また競合状況、主要企業情報（12社）、市場ダイナミクス、バリューチェーン分析などの分析も加味し、生体材料用コラーゲンおよびゼラチン市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆生体材料用コラーゲンおよびゼラチンの世界市場予測2021-2028年
・市場規模(US$)
◆由来原料別、市場-2028年
・牛コラーゲン/ゼラチン
・豚コラーゲン/ゼラチン
・その他コラーゲン/ゼラチン
※(市場規模US$)
※コラーゲン/ゼラチン個別にデータ掲載
◆コラーゲン市場、用途別、市場-2028年
・整形外科
・創傷ケア
・歯科
・外科
・心臓血管
・その他用途
※(市場規模US$)
◆ゼラチン市場、用途別、市場-2028年
・整形外科
・創傷ケア
・その他用途
※(市場規模US$)
◆エンドユーザー別、市場-2028年
・病院
・外科センター
※(市場規模US$)
◆主要国地域別市場-2028年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
その他地域
・中南米
・中東
・アフリカ
※「その他地域」以外は、国地域別に全セグメント別の細分化データ掲載、詳細は目次参照
※「その他地域」は、コラーゲン市場のみ各種セグメント別の細分化データ掲載。
◆市場分析
・市場ダイナミクス（促進要因、障壁、機会、課題）
・バリューチェーン分析
・サプライチェーン分析
・業界構造分析（ファイブフォース分析）
・規制分析
・価格分析
・競合状況
・市場シェア分析
◆生体材料用コラーゲンおよびゼラチンの主要企業プロフィール動向
・INTEGRA LIFESCIENCES
・DSM
・新田ゼラチン株式会社
・COLLPLANT BIOTECHNOLOGIES LTD.
・COLLAGEN SOLUTIONS PLC
・REGENITY
・SYMATESE
・GELITA AG
・TESSENDERLO GROUP (BU PB LINER)
・SMITH & NEPHEW PLC
・ZIMVIE INC.
・JELLAGEN
（その他企業）
・ADVANCED BIOMATRIX
・MATRICEL GMBH
・ROUSSELOT
・WEISHARDT
・XIAMEN HYFINE GELATIN CO., LTD.
・GEISTLICH PHARMA AG
・SYNERHEAL PHARMACEUTICALS
・BIOREGEN TECHNOLOGIES
・MERIL LIFE SCIENCES PVT. LTD.
・MEDSKIN SUWELACK
・COLOGENESIS HEALTHCARE PVT LTD
・DERMARITE INDUSTRIES, LLC.
・EUCARE PHARMACEUTICALS PRIVATE LIMITED
（全234頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 YEARS CONSIDERED 30
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS 31
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT 32
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 1 COLLAGEN AND GELATIN MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
・ FIGURE 2 COLLAGEN AND GELATIN MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
・ FIGURE 3 COLLAGEN AND GELATIN MARKET SIZE ESTIMATION, 2022
・ FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
・ FIGURE 5 ILLUSTRATIVE EXAMPLE OF INTEGRA LIFESCIENCES: REVENUE SHARE ANALYSIS, 2022
2.2.1 INSIGHTS FROM PRIMARIES
・ FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY EXPERTS
2.2.2 SEGMENTAL ASSESSMENT (BY SOURCE, APPLICATION, AND END USER): TOP-DOWN APPROACH
・ FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS
・ FIGURE 8 COLLAGEN AND GELATIN MARKET: CAGR PROJECTIONS, 2023–2028
・ FIGURE 9 COLLAGEN AND GELATIN MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
・ FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 IMPACT OF RECESSION ON COLLAGEN AND GELATIN MARKET
・ TABLE 1 GLOBAL INFLATION RATE, 2021–2028 (%)
・ TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
・ TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
・ FIGURE 11 COLLAGEN AND GELATIN MARKET, BY SOURCE, 2023 VS. 2028 (USD MILLION)
・ FIGURE 12 COLLAGEN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
・ FIGURE 13 GELATIN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
・ FIGURE 14 COLLAGEN AND GELATIN MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
・ FIGURE 15 REGIONAL SNAPSHOT OF COLLAGEN AND GELATIN MARKET
4 PREMIUM INSIGHTS
4.1 GROWTH OPPORTUNITIES FOR PLAYERS IN COLLAGEN AND GELATIN MARKET
・ FIGURE 16 INCREASED PREVALENCE OF DIABETES AND CANCER TO DRIVE MARKET
4.2 COLLAGEN AND GELATIN MARKET IN NORTH AMERICA, BY SOURCE AND COUNTRY, 2022
・ FIGURE 17 BOVINE AND US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN COLLAGEN AND GELATIN MARKET, BY SOURCE AND COUNTRY, RESPECTIVELY, IN 2022
4.3 COLLAGEN AND GELATIN MARKET SHARE, BY SOURCE, 2023 VS. 2028
・ FIGURE 18 BOVINE SEGMENT TO DOMINATE MARKET IN 2028
4.4 COLLAGEN AND GELATIN MARKET SHARE, BY END USER, 2022
・ FIGURE 19 HOSPITALS SEGMENT HELD LARGER MARKET SHARE IN 2022
4.5 COLLAGEN AND GELATIN MARKET GROWTH OPPORTUNITIES, BY COUNTRY,
2023–2028
・ FIGURE 20 JAPAN TO REGISTER SECOND-HIGHEST CAGR IN COLLAGEN MARKET FROM 2023 TO 2028
・ FIGURE 21 CHINA TO EXHIBIT HIGHEST CAGR IN GELATIN MARKET DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 22 COLLAGEN AND GELATIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
・ TABLE 4 COLLAGEN AND GELATIN MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 INCREASING PREVALENCE OF DIABETES & CHRONIC WOUNDS AND CANCER 55
5.2.1.2 RISING INVESTMENTS AND FUNDING IN R&D OF COLLAGEN AND GELATIN PRODUCTS
5.2.1.3 GROWING NUMBER OF SURGICAL PROCEDURES
・ TABLE 5 NUMBER OF SURGERIES PERFORMED IN US, 2022–2023
5.2.2 RESTRAINTS
5.2.2.1 AVAILABILITY OF ALTERNATIVE BIOMATERIALS TO COLLAGEN AND GELATIN
5.2.3 OPPORTUNITIES
5.2.3.1 ENFORCEMENT OF 21ST CENTURY CURES ACT
5.2.4 CHALLENGES
5.2.4.1 LACK OF ADVANCED MANUFACTURING AND MARKETING TECHNOLOGIES
5.3 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR PLAYERS IN COLLAGEN AND GELATIN MARKET
・ FIGURE 23 INCREASED USE OF COLLAGEN AND GELATIN PRODUCTS IN WOUND CARE AND SURGICAL PROCEDURES IS LIKELY TO HAVE POSITIVE IMPACT ON THE GROWTH OF THE MARKET
5.4 VALUE CHAIN ANALYSIS
・ FIGURE 24 COLLAGEN AND GELATIN MARKET: VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN
・ FIGURE 25 SUPPLY CHAIN OF COLLAGEN & GELATIN MARKET
5.6 COLLAGEN AND GELATIN MARKET: ECOSYSTEM ANALYSIS
5.7 TECHNOLOGY ANALYSIS
5.8 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 6 COLLAGEN AND GELATIN MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 REGULATORY ANALYSIS
5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 11 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10 PATENT ANALYSIS
・ FIGURE 26 PATENTS GRANTED FOR COLLAGEN MARKET, JUNE 2013–JUNE 2023
5.10.1 LIST OF MAJOR PATENTS
・ FIGURE 27 PATENTS GRANTED FOR GELATIN MARKET, JUNE 2013–JUNE 2023
5.11 KEY CONFERENCES AND EVENTS, 2023–2024
・ TABLE 12 COLLAGEN AND GELATIN MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
5.12 PRICING ANALYSIS
5.12.1 AVERAGE SELLING PRICE TREND ANALYSIS
・ TABLE 13 GELATIN MARKET: AVERAGE SELLING PRICE, BY SOURCE AND REGION, 2022–2023 (USD/KG)
・ TABLE 14 PORCINE GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG)
・ TABLE 15 BOVINE SKIN GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG)
・ TABLE 16 BOVINE BONE GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG)
・ TABLE 17 FISH & POULTRY GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG)
・ TABLE 18 OTHER ANIMAL SOURCES GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG)
・ TABLE 19 PLANT-SOURCED GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG)
5.13 PRICING ANALYSIS
5.13.1 AVERAGE SELLING PRICE TREND ANALYSIS
・ TABLE 20 BOVINE: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON)
・ TABLE 21 PORCINE: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON)
・ TABLE 22 POULTRY: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON)
・ TABLE 23 MARINE: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON)
・ TABLE 24 PLANT SOURCES: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON)
・ TABLE 25 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY MARKET PLAYERS, BY SOURCE, 2022 (USD/TON)
5.13.2 KEY STAKEHOLDERS IN BUYING PROCESS
・ FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COLLAGEN AND GELATIN PRODUCTS
5.13.3 BUYING CRITERIA
・ FIGURE 29 KEY BUYING CRITERIA FOR END USERS
6 COLLAGEN AND GELATIN MARKET, BY SOURCE
6.1 INTRODUCTION
・ TABLE 26 COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 27 GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
6.2 BOVINE COLLAGEN AND GELATIN SOURCES
6.2.1 INCREASED USE IN TISSUE ENGINEERING APPLICATIONS TO DRIVE MARKET
・ TABLE 28 BOVINE: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 29 NORTH AMERICA: COLLAGEN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 30 EUROPE: COLLAGEN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 31 ASIA PACIFIC: COLLAGEN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 32 BOVINE: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 33 NORTH AMERICA: GELATIN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 34 EUROPE: GELATIN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 35 ASIA PACIFIC: GELATIN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 PORCINE COLLAGEN AND GELATIN SOURCES
6.3.1 LOW ALLERGIC RESPONSE AND BIOCOMPATIBILITY OF PORCINE COLLAGEN AND GELATIN TO BOOST DEMAND
・ TABLE 36 PORCINE: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 37 NORTH AMERICA: COLLAGEN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 38 EUROPE: COLLAGEN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 39 ASIA PACIFIC: COLLAGEN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 40 PORCINE: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 41 NORTH AMERICA: GELATIN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 42 EUROPE: GELATIN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 43 ASIA PACIFIC: GELATIN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 OTHER COLLAGEN AND GELATIN SOURCES
・ TABLE 44 OTHER SOURCES: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 45 NORTH AMERICA: COLLAGEN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 46 EUROPE: COLLAGEN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 47 ASIA PACIFIC: COLLAGEN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 48 OTHER SOURCES: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 49 NORTH AMERICA: GELATIN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 50 EUROPE: GELATIN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 51 ASIA PACIFIC: GELATIN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
7 COLLAGEN MARKET, BY APPLICATION
7.1 INTRODUCTION
・ TABLE 52 COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
7.2 ORTHOPEDIC 93
7.2.1 INCREASING USE OF COLLAGEN IN ORTHOPEDIC SURGERIES TO DRIVE MARKET
・ TABLE 53 ORTHOPEDIC: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 54 NORTH AMERICA: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 55 EUROPE: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 56 ASIA PACIFIC: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 WOUND CARE 96
7.3.1 RISING PREVALENCE OF CHRONIC WOUND CONDITIONS TO BOOST COLLAGEN ADOPTION
・ TABLE 57 WOUND CARE: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 58 NORTH AMERICA: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 59 EUROPE: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 60 ASIA PACIFIC: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 DENTAL
7.4.1 RISING INCIDENCE OF ORAL DISORDERS TO DRIVE MARKET
・ TABLE 61 DENTAL: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 62 NORTH AMERICA: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 63 EUROPE: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 64 ASIA PACIFIC: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 SURGICAL
7.5.1 INCREASING NUMBER OF SURGICAL PROCEDURES GLOBALLY TO BOOST DEMAND FOR COLLAGEN PRODUCTS
・ TABLE 65 SURGICAL: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 66 NORTH AMERICA: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 67 EUROPE: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 68 ASIA PACIFIC: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.6 CARDIOVASCULAR
7.6.1 GROWING USE OF COLLAGEN PATCHES TO IMPROVE HEART FUNCTION TO SUPPORT MARKET GROWTH
・ TABLE 69 CARDIOVASCULAR: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 70 NORTH AMERICA: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 71 EUROPE: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 72 ASIA PACIFIC: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.7 OTHER APPLICATIONS
・ TABLE 73 OTHER APPLICATIONS: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 74 NORTH AMERICA: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 75 EUROPE: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 76 ASIA PACIFIC: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8 GELATIN MARKET, BY APPLICATION
8.1 INTRODUCTION
・ TABLE 77 GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 ORTHOPEDIC 109
8.2.1 USE OF GELATIN IN BONE AND CARTILAGE REGENERATION TREATMENT TO DRIVE MARKET
・ TABLE 78 ORTHOPEDIC: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 79 NORTH AMERICA: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 80 EUROPE: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 81 ASIA PACIFIC: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 WOUND CARE 112
8.3.1 APPLICATION OF GELATIN-BASED HYDROGELS IN TREATING BURNS TO DRIVE MARKET
・ TABLE 82 WOUND CARE: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 83 NORTH AMERICA: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 84 EUROPE: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 85 ASIA PACIFIC: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 OTHER APPLICATIONS
・ TABLE 86 OTHER APPLICATIONS: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 87 NORTH AMERICA: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 88 EUROPE: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 89 ASIA PACIFIC: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
9 COLLAGEN AND GELATIN MARKET, BY END USER
9.1 INTRODUCTION
・ TABLE 90 COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
・ TABLE 91 GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 HOSPITALS 119
9.2.1 SIGNIFICANT USE OF BIOSURGERY PRODUCTS IN HOSPITALS
・ TABLE 92 HOSPITALS: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 93 NORTH AMERICA: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 94 EUROPE: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 95 ASIA PACIFIC: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 96 HOSPITALS: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 97 NORTH AMERICA: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 98 EUROPE: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 99 ASIA PACIFIC: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 SURGICAL CENTERS
9.3.1 AVAILABILITY OF HIGH-QUALITY AND LOW-COST MEDICAL SERVICES AT SURGICAL CENTERS
・ TABLE 100 SURGICAL CENTERS: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 101 NORTH AMERICA: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 102 EUROPE: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 103 ASIA PACIFIC: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 104 SURGICAL CENTERS: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 105 NORTH AMERICA: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 106 EUROPE: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 107 ASIA PACIFIC: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
10 COLLAGEN AND GELATIN MARKET, BY REGION
10.1 INTRODUCTION
・ TABLE 108 COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 109 GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
・ FIGURE 30 NORTH AMERICA: COLLAGEN MARKET SNAPSHOT
・ TABLE 110 NORTH AMERICA: COLLAGEN MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 111 NORTH AMERICA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 112 NORTH AMERICA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 113 NORTH AMERICA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
・ FIGURE 31 NORTH AMERICA: GELATIN MARKET SNAPSHOT
・ TABLE 114 NORTH AMERICA: GELATIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 115 NORTH AMERICA: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 116 NORTH AMERICA: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 117 NORTH AMERICA: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 INCREASING INCIDENCE OF PERIODONTITIS AND BURN INJURIES TO DRIVE MARKET
・ TABLE 118 US: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 119 US: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 120 US: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
・ TABLE 121 US: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 122 US: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 123 US: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 GROWING GERIATRIC POPULATION AND VOLUME OF SURGERIES TO BOOST COLLAGEN AND GELATIN DEMAND
・ TABLE 124 CANADA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 125 CANADA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 126 CANADA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
・ TABLE 127 CANADA: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 128 CANADA: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 129 CANADA: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 RECESSION IMPACT ON MARKET IN NORTH AMERICA
10.3 EUROPE
・ TABLE 130 EUROPE: COLLAGEN MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 131 EUROPE: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 132 EUROPE: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 133 EUROPE: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
・ TABLE 134 EUROPE: GELATIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 135 EUROPE: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 136 EUROPE: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 137 EUROPE: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 INCREASE IN HEALTHCARE EXPENDITURE TO BOOST ADOPTION OF COLLAGEN AND GELATIN PRODUCTS
・ TABLE 138 GERMANY: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 139 GERMANY: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 140 GERMANY: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
・ TABLE 141 GERMANY: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 142 GERMANY: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 143 GERMANY: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 UK
10.3.2.1 HIGH RISK OF PRESSURE ULCERS IN DIABETIC PATIENTS TO DRIVE MARKET
・ TABLE 144 UK: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 145 UK: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 146 UK: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
・ TABLE 147 UK: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 148 UK: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 149 UK: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 WELL-ESTABLISHED HEALTHCARE SECTOR TO PROVIDE LUCRATIVE OPPORTUNITIES TO COLLAGEN AND GELATIN VENDORS
・ TABLE 150 FRANCE: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 151 FRANCE: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 152 FRANCE: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
・ TABLE 153 FRANCE: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 154 FRANCE: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 155 FRANCE: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 REST OF EUROPE
・ TABLE 156 REST OF EUROPE: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 157 REST OF EUROPE: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 158 REST OF EUROPE: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
・ TABLE 159 REST OF EUROPE: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 160 REST OF EUROPE: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 161 REST OF EUROPE: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 RECESSION IMPACT ON MARKET IN EUROPE
10.4 ASIA PACIFIC
・ FIGURE 32 ASIA PACIFIC: COLLAGEN MARKET SNAPSHOT
・ TABLE 162 ASIA PACIFIC: COLLAGEN MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 163 ASIA PACIFIC: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 164 ASIA PACIFIC: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 165 ASIA PACIFIC: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
・ FIGURE 33 ASIA PACIFIC: GELATIN MARKET SNAPSHOT
・ TABLE 166 ASIA PACIFIC: GELATIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 167 ASIA PACIFIC: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 168 ASIA PACIFIC: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 169 ASIA PACIFIC: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 RISING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
・ TABLE 170 JAPAN: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 171 JAPAN: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 172 JAPAN: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
・ TABLE 173 JAPAN: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 174 JAPAN: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 175 JAPAN: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.2 CHINA
10.4.2.1 SIGNIFICANT ELDERLY POPULATION WITH DIABETES TO PUSH DEMAND FOR COLLAGEN AND GELATIN PRODUCTS
・ TABLE 176 CHINA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 177 CHINA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 178 CHINA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
・ TABLE 179 CHINA: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 180 CHINA: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 181 CHINA: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 INCREASING HEALTHCARE SPENDING BY GOVERNMENT TO STIMULATE MARKET GROWTH
・ TABLE 182 INDIA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 183 INDIA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 184 INDIA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
・ TABLE 185 INDIA: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 186 INDIA: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 187 INDIA: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
・ TABLE 188 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 189 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 190 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
・ TABLE 191 REST OF ASIA PACIFIC: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 192 REST OF ASIA PACIFIC: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 193 REST OF ASIA PACIFIC: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.5 RECESSION IMPACT ON MARKET IN ASIA PACIFIC
10.5 REST OF THE WORLD (ROW)
・ TABLE 194 ROW: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 195 ROW: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 196 ROW: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 197 ROW: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
・ TABLE 198 ROW: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 199 ROW: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 200 ROW: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.1 LATIN AMERICA
10.5.1.1 INCREASING NUMBER OF DIABETIC PATIENTS TO RISE DEMAND FOR COLLAGEN AND GELATIN PRODUCTS
・ TABLE 201 LATIN AMERICA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 202 LATIN AMERICA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 203 LATIN AMERICA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 RECESSION IMPACT ON MARKET IN LATIN AMERICA
10.5.3 MIDDLE EAST & AFRICA
10.5.3.1 GROWING FOCUS ON HEALTHCARE INFRASTRUCTURE IMPROVEMENT TO DRIVE MARKET 180
・ TABLE 204 MIDDLE EAST & AFRICA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION)
・ TABLE 205 MIDDLE EAST & AFRICA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.4 RECESSION IMPACT ON MARKET IN MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
・ FIGURE 34 COLLAGEN AND GELATIN MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS
・ FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
11.4 MARKET SHARE ANALYSIS
・ FIGURE 36 COLLAGEN AND GELATIN MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
・ TABLE 206 COLLAGEN AND GELATIN MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
・ FIGURE 37 COLLAGEN AND GELATIN MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
11.6.1 PRODUCT FOOTPRINT OF 25 COMPANIES
・ TABLE 207 COLLAGEN AND GELATIN MARKET: COMPANY PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
11.6.2 REGIONAL FOOTPRINT OF 25 COMPANIES
・ TABLE 208 COLLAGEN AND GELATIN MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
11.7 COMPANY EVALUATION MATRIX: START-UPS/SMES
・ FIGURE 38 COLLAGEN AND GELATIN MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
11.7.1 PROGRESSIVE COMPANIES
11.7.2 STARTING BLOCKS
11.7.3 RESPONSIVE COMPANIES
11.7.4 DYNAMIC COMPANIES
11.8 COMPETITIVE BENCHMARKING OF START-UP/SMES
・ TABLE 209 COLLAGEN AND GELATIN MARKET: DETAILED LIST OF KEY START-UPS/SMES
・ TABLE 210 COLLAGEN AND GELATIN MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
11.9 COMPETITIVE SCENARIOS AND TRENDS
11.9.1 PRODUCT LAUNCHES
・ TABLE 211 COLLAGEN AND GELATIN MARKET: PRODUCT LAUNCHES, JANUARY 2020–APRIL 2023
11.9.2 DEALS
・ TABLE 212 COLLAGEN AND GELATIN MARKET: DEALS, JANUARY 2020–APRIL 2023
12 COMPANY PROFILES
12.1 KEY MARKET PLAYERS
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
12.1.1 INTEGRA LIFESCIENCES
・ TABLE 213 INTEGRA LIFESCIENCES: COMPANY OVERVIEW
・ FIGURE 39 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
12.1.2 DSM
・ TABLE 214 ROYAL DSM: COMPANY OVERVIEW 199
・ FIGURE 40 DSM: COMPANY SNAPSHOT
12.1.3 NITTA GELATIN INC.
・ TABLE 215 NITTA GELATIN INC.: COMPANY OVERVIEW
・ FIGURE 41 NITTA GELATIN INC.: COMPANY SNAPSHOT
12.1.4 COLLPLANT BIOTECHNOLOGIES LTD.
・ TABLE 216 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY OVERVIEW
・ FIGURE 42 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT
12.1.5 COLLAGEN SOLUTIONS PLC
・ TABLE 217 COLLAGEN SOLUTIONS PLC: COMPANY OVERVIEW
12.1.6 REGENITY
・ TABLE 218 REGENITY: COMPANY OVERVIEW 209
12.1.7 SYMATESE
・ TABLE 219 SYMATESE: COMPANY OVERVIEW 211
12.1.8 GELITA AG
・ TABLE 220 GELITA AG: COMPANY OVERVIEW 212
・ TABLE 221 GELITA AG: DEALS
12.1.9 TESSENDERLO GROUP (BU PB LINER)
・ TABLE 222 TESSENDERLO GROUP (BU PB LINER): COMPANY OVERVIEW
・ FIGURE 43 TESSENDERLO GROUP (BU PB LINER): COMPANY SNAPSHOT
・ TABLE 223 TESSENDERLO GROUP: DEALS
12.1.10 SMITH & NEPHEW PLC
・ TABLE 224 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
・ FIGURE 44 SMITH & NEPHEW PLC: COMPANY SNAPSHOT
12.1.11 ZIMVIE INC.
・ TABLE 225 ZIMVIE INC.: COMPANY OVERVIEW
12.1.12 JELLAGEN
・ TABLE 226 JELLAGEN: COMPANY OVERVIEW 221
・ TABLE 227 JELLAGEN: PRODUCT OFFERINGS 221
12.2 OTHER PLAYERS
12.2.1 ADVANCED BIOMATRIX
12.2.2 MATRICEL GMBH
12.2.3 ROUSSELOT
12.2.4 WEISHARDT
12.2.5 XIAMEN HYFINE GELATIN CO., LTD.
12.2.6 GEISTLICH PHARMA AG
12.2.7 SYNERHEAL PHARMACEUTICALS
12.2.8 BIOREGEN TECHNOLOGIES
12.2.9 MERIL LIFE SCIENCES PVT. LTD.
12.2.10 MEDSKIN SUWELACK
12.2.11 COLOGENESIS HEALTHCARE PVT LTD
12.2.12 DERMARITE INDUSTRIES, LLC
12.2.13 EUCARE PHARMACEUTICALS PRIVATE LIMITED
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS